INTRODUCTION
The neurochemical mechanisms that mediate the behavioral effects of cocaine are complex and likely involve multiple neurotransmitter systems. In vitro studies have demonstrated that cocaine blocks the uptake of the monoamines, dopamine, serotonin, and norepinephrine (Heikkila and Manzino, 1984; Reith et al., 1986) . However, the behavioral effects of cocaine have been linked more closely to inhibition of dopamine uptake (Ritz et al., 1987; Woolverton and Kleven, 1988) . Evidence to support this conclusion is derived from a variety of behavioral studies characterizing the acute effects of dopamine transporter (DAT) inhibitors administered alone or in combination with cocaine. Preclinical studies have demonstrated a relationship between the potency of cocaine analogs at binding to the DAT in vitro and their potency in producing locomotor-stimulant effects in rodents (Cline et al., 1992; Kuhar, 1993) . Similarly, a high correlation was found between the potency of cocaine analogs to displace [ JPET #108324 p. 12 Procedure. Subjects responded for i.v. infusions of cocaine or M&Ms under a multiple, second-order schedule of reinforcement. When the daily session began, the red light on the response panel was illuminated and indicated availability of food reinforcement. Each fixed ratio of 20 responses (FR20) completed during a 10-minute fixed interval changed the stimulus light from red to white for 2 seconds. The first FR20 completed after the 10-minute fixed-interval had elapsed resulted in the simultaneous delivery of 3 M&Ms into a tray located in the lower center portion of the response panel, and changed the stimulus light from red to white for 15 seconds. There was a 30-second limited hold for completion of the first FR20 after the 10-minute fixed-interval had elapsed, and food was not delivered if the limited hold expired. The purpose of the limited hold was to limit the component duration and to require a minimal rate of responding in order for the subject to receive a reinforcer. After the food delivery or the limited hold expired, there was a 1-minute timeout during which all stimulus lights were extinguished and responding on the lever had no programmed consequences. When the second component of the daily session began, the green light was illuminated and indicated availability of cocaine reinforcement. Otherwise, all schedule parameters were identical to the food component. The food and cocaine components continued to alternate during a daily session until each component was presented three times.
The sequence of drug treatments and subject assignment for the entire study are shown in Table 1 . The 6 subjects were assigned to overlapping protocols to ensure that N=4 for each experimental condition. Unfortunately, subject REl-5 died due to health problems unrelated to the study and was unable to complete the SERT inhibitor coadministration experiments. The training conditions described above remained in effect until responding for 0.1 mg/kg/injection cocaine and food was stable (<20% variance in daily response rate over 5 consecutive sessions), after which saline was substituted for cocaine until responding in the cocaine component decreased to below 30% of responding for the training dose of cocaine. Typically, response rates declined gradually over 2-4 sessions. After saline extinction, the maintenance dose of cocaine was reinstated and responding was allowed to stabilize (<20% variance in daily response rate over 5 consecutive sessions).
For cocaine substitution studies, each subject was allowed to self-administer several doses of cocaine in random order. Substitution for each drug dose continued for at least 5 consecutive sessions and until responding stabilized (<20% variance in daily response rate). Typically, stable performance required 9-12 sessions for a given drug dose.
For pretreatment studies, a given dose of RTI-336 was administered i.v. 15 minutes pre-session for 5 consecutive days. No trend was present across treatment days for any drug dose, so daily response rates were averaged across the 5 days.
Saline vehicle was administered on alternate weeks and served as the control condition for drug pretreatment effects. There was little variation in response rates over multiple blocks of saline pretreatments, indicating that cocaine self-administration was stable in the absence of RTI-336 pretreatments. Each pretreatment dose was administered on at least two separate occasions and the sequence of doses was quasi-random. Data for individual subjects were based on the mean response rate over multiple determinations at each dose. All doses of RTI-336 were studied in combination with 0.1 mg/kg/infusion cocaine first. Subsequently, the maintenance dose of cocaine was changed to 0.3 JPET #108324 p. 14 mg/kg/infusion and responding was allowed to stabilize. Drug pretreatments were repeated as described above for the lower maintenance dose of cocaine.
For RTI-336 substitution studies, each subject was allowed to self-administer several doses of RTI-336 in random order. Substitution for each drug dose continued for at least 5 consecutive sessions and until responding stabilized (<20% variance in daily response rate). Typically, stable performance required 10-15 sessions for a given drug dose. RTI-336 was the only drug available during these substitution studies. Two subjects (RNa-4 and ROk-5) assigned to RTI-336 substitution studies first participated in the RTI-336 pretreatment studies as described above. The other two subjects (RMy-4 and RRj-5) only had a history of cocaine self-administration.
The dose of RTI-336 that reduced cocaine self-administration by 50% of baseline (ED 50 ) was determined for individual subjects, and subsequently administered in combination with the SERT inhibitors, fluoxetine (3.0 mg/kg) or citalopram (3.0 mg/kg) while subjects self-administered the 0.1 mg/kg/injection maintenance dose of cocaine.
The pretreatment doses of fluoxetine and citalopram were the highest doses that could be administered without producing overt behavioral effects when given alone (Czoty et al., 2002; Spealman, 1993) . In one condition, the SERT inhibitors were administered i.m. chronically for 4 consecutive weeks, and RTI-336 was administered during the last week of treatment. The 4-week treatment period with the SERT inhibitors was selected on the basis of the time-course of therapeutic effects observed in the treatment of depression. In the other condition, the SERT inhibitors were administered i.m. acutely for 5 consecutive days during co-administration of RTI-336. The 5-day treatment period with the SERT inhibitors was selected in order to detect potential changes in sensitivity JPET #108324 p. 15 associated with repeated dosing. The order of drug testing was chronic fluoxetine, acute fluoxetine, acute citalopram, and chronic citalopram. Lastly, the dose of RTI-336 that reduced cocaine self-administration by 10% of baseline (ED 10 ) was determined for individual subjects, and subsequently administered in combination with fluoxetine (3.0 mg/kg) while subjects self-administered the 0.1 mg/kg/injection maintenance dose of cocaine. The rationale for evaluating the lower, ED 10 , dose of RTI-336 was to determine whether robust effects of the DAT inhibitor are required in order to observe drug interactions during co-administration with fluoxetine. Fluoxetine was administered i.m acutely for 5 consecutive days during co-administration of RTI-336. In all coadministration studies, the SERT inhibitor was administered i.m 30 minutes pre-session and RTI-336 was administered i.v. 15 minutes pre-session. Subjects self-administered the maintenance dose of cocaine alone for at least 2 consecutive weeks between each experimental condition involving co-administration of a SERT inhibitor in order to reestablish stable self-administration behavior (<20% variance in daily response rate). have yielded equivocal results concerning selectivity of drug pretreatment effects.
GBR12909 selectively attenuated cocaine-maintained behavior compared with foodmaintained behavior in food-deprived rhesus monkeys at a low unit dose of cocaine but not at a high unit dose (Glowa et al., 1995) . Similarly, administration of cocaine as a continuous infusion had selective effects on cocaine-maintained behavior compared to food-maintained behavior only at low unit doses of self-administered cocaine (Glowa and Fantegrossi, 1997) . However, other studies with monoamine transporter inhibitors have demonstrated nonselective reductions in cocaine-maintained behavior and behavior maintained by alternate reinforcers (Kleven and Woolverton, 1993; Howell et al., 2000) . It should be emphasized that the subjects in the present study were not food-deprived. Moreover, the food and cocaine components alternated during daily one-hour sessions. Responding maintained by food presentation was suppressed in the absence of drug pretreatments when the unit dose of cocaine was increased to 0.3 mg/kg/injection. Hence the conditions were not optimal to maintain robust foodmaintained behavior during drug pre-treatment studies. Selective reductions in cocainemaintained behavior would have been a preferred outcome from the standpoint of medications development. However, no adverse behavioral effects were observed at any pretreatment dose of RTI-336 administered alone or in combination with the SERT inhibitors, and food intake and body weight were unaffected over the course of the study.
A possible limitation to the use of selective DAT inhibitors as medications for treatment of cocaine addiction is their potential for abuse, given their documented reinforcing JPET #108324 p. 27 effects (Howell and Wilcox, 2001) . In the present study, RTI-336 reliably maintained self-administration behavior in all subjects, consistent with results reported for phenyltropanes (Howell et al., 2000; Wilcox et al., 2002; Lindsey et al., 2004 ) and the phenylpiperazine, GBR12909 (Bergman et al., 1989; Howell and Byrd, 1991; Lindsey et al., 2004) in nonhuman primates. In fact, DAT occupancy at the dose of RTI-336 that maintained peak responding was actually less than DAT occupancy at the ED 50 dose for suppressing cocaine self-administration. The bolus dosing protocol used for estimating occupancy associated with self-administration doses of RTI-336 may have overestimated actual occupancy obtained following repeated injections of the unit dose.
The finding that lower DAT occupancy was associated with the reinforcing effects of RTI-336 compared to its effects in reducing cocaine self-administration may be problematic from the standpoint of medications development. However, RTI-336 maintained lower rates of responding compared with cocaine across a broad range of doses, even though DAT occupancy was equal to or greater than that observed for cocaine (Wilcox et al., 2002) . In behavioral studies in rodents and nonhuman primates, these compounds had a slower onset and a longer duration of action compared with cocaine (Howell et al., 2000; Kimmel et al., 2001) . The pharmacokinetic data reported in the present study also documented a longer duration of action for RTI-336 compared to cocaine. Hence, the reinforcing effects and pattern of drug self-administration may be influenced by pharmacokinetics in addition to steady-state levels of DAT occupancy.
It is interesting to note that DAT occupancy at the doses of RTI-336 that maintained peak rates of responding was equivalent for two subjects even though the doses JPET #108324 p. 28 differed by 1.0 log units. Moreover, there was no obvious difference in their drug histories that may account for this finding. In general, there did not appear to be a close relationship between absolute drug dose in mg/kg and DAT occupancy when comparing data across subjects. However, note that the doses selected for individual subjects in DAT occupancy determinations were functionally equivalent based on RTI-336 selfadministration or RTI-336-induced reductions in cocaine self-administration. Hence, when subjects received functionally equivalent doses of RTI-336, the corresponding values for DAT occupancy were fairly consistent.
The reinforcing effects of DAT inhibitors also may be limited by dual actions at the SERT. The mixed action DAT/SERT inhibitor, RTI-112, was not reliably selfadministered when substituted for cocaine, yet suppressed cocaine self-administration at low levels of DAT occupancy in rhesus monkeys (Lindsey et al., 2004) . Similarly, monoamine-releasing agents had decreasing reinforcing effectiveness in rhesus monkeys when serotonin releasing potency was increased relative to dopamine (Wee et al., 2005) . Accordingly, combined inhibition of DAT and SERT may be effective in reducing cocaine use and limit the reinforcing effectiveness and abuse liability of the potential medications. Paradoxically, cocaine is a nonselective inhibitor of DAT and SERT, and it is a robust reinforcer with high abuse liability. However, cocaine exhibits a different pharmacokinetic profile and has lower affinity for DAT and SERT compared to the compounds being considered as pharmacotherapies.
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Compelling data have emerged from clinical research supporting indirect agonist-like pharmacotherapy for stimulant abuse and dependence (Grabowski et al., 2004) . The concept of indirect agonist pharmacotherapy implies that the medication will exhibit some cocaine-like properties at a neurochemical and behavioral level. In this regard, selective SERT inhibitors do not exhibit cocaine-like behavioral effects and do not seem appropriate as indirect agonist pharmacotherapies (Grabowski et al., 1995) . In contrast, 
